Table 2. Study results and summary .
| No. |
No pleural effusion
(x-ray 1-month) |
Improved ECOG w/ residual pleural effusion with (x-ray 1-month) | Success | |
| Pre-op LENT Score | ||||
| Low-risk | 1 (2.2%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Moderate-risk | 31 (68.8%) | 15 (48.3%) | 15 (48.3%) | 30 (96.7%) |
| High-risk | 13 (28.8%) | 10 (76.9%) | 2 (15.4%) | 12 (92.3%) |
| Post-op ECOG score | 2±1.7 | |||
| Days w/tube | 5±2.4 | |||
| Peri-operative mortality | 1 (2%) | |||
| Post-op pain | 9 (20%) | |||
|
Complications Pleural fistula Pneumothorax Chylothorax Fever Bleeding Respiratory failure Re-operation/Decortication Total |
2 4%) 1 (2%) 1 (2%) 1 (2%) 1 (2%) 1 (2%) 1 (2%) 8 (17.7%) |
|||
| Total | 25 (55.5%) | 17 (37.7%) | 42 (93.3%) | |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; LENT, lactate, ECOG, neutrophil-lymphocyte ratio, tumor type